Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infections After HSCT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT04832607
What this trial is testing

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

Who this might be right for
AdV InfectionEBV InfectionCMV Infection+1 more
Tobias Feuchtinger 149
Very early researchLooking for participantsNCT03665675
What this trial is testing

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientCytomegalovirusDonor+2 more
Sumithira Vasu 20
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Testing effectiveness (Phase 2)UnknownNCT06075927
What this trial is testing

Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT

Who this might be right for
CMV InfectionEBV InfectionStem Cell Transplant
Peking University People's Hospital 29
Testing effectiveness (Phase 2)Study completedNCT00006251
What this trial is testing

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more
Fred Hutchinson Cancer Center 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07261215
What this trial is testing

Zuberitamab for EBV Infection Post-Allo-HSCT

Who this might be right for
HSCTEBV Infection
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT00148148
What this trial is testing

Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell TransplantationFungus Diseases
University Hospital Muenster 75
Early research (Phase 1)Study completedNCT00078533
What this trial is testing

Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant

Who this might be right for
Cytomegalovirus Infections
Baylor College of Medicine 26
Testing effectiveness (Phase 2)Study completedNCT03067155
What this trial is testing

CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.

Who this might be right for
Hematological MalignanciesCMV Infection
University Hospital, Ghent 1
Testing effectiveness (Phase 2)Study completedNCT03940586
What this trial is testing

Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)

Who this might be right for
Cytomegalovirus (CMV) Infection
Merck Sharp & Dohme LLC 65
Large-scale testing (Phase 3)Study completedNCT02942173
What this trial is testing

CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 150
Not applicableStudy completedNCT01481649
What this trial is testing

Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) Exposure

Who this might be right for
Exposure to Hepatitis B Virus
The University of Hong Kong 69
Testing effectiveness (Phase 2)Study completedNCT02136797
What this trial is testing

Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
CMV InfectionPersistent CMV Viremia
Memorial Sloan Kettering Cancer Center 77
Large-scale testing (Phase 3)Ended earlyNCT00241345
What this trial is testing

Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant

Who this might be right for
Cytomegalovirus Infections
Washington University School of Medicine 39
Large-scale testing (Phase 3)Study completedNCT00002649
What this trial is testing

Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Diffuse Mixed Cell Lymphoma+5 more
National Cancer Institute (NCI) 206
Testing effectiveness (Phase 2)Study completedNCT00053196
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+3 more
Alliance for Clinical Trials in Oncology 82
Early research (Phase 1)Study completedNCT01588015
What this trial is testing

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+123 more
City of Hope Medical Center 36
Testing effectiveness (Phase 2)Study completedNCT01570283
What this trial is testing

ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus

Who this might be right for
Viral Infection
AlloVir 21
Early research (Phase 1)Study completedNCT01070797
What this trial is testing

Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)

Who this might be right for
Adenovirus InfectionEpstein-Barr Virus InfectionsCytomegalovirus Infections+1 more
Baylor College of Medicine 10
Testing effectiveness (Phase 2)Study completedNCT00357084
What this trial is testing

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 53
Next Page